weight loss drug prescriptions semaglutide tirzepatide q3 2024 data Dynamics and Health Burden Changes with versus Outlook for Obesity in 2026:

Faster hydration = faster recovery

The pill is licensed for adults with obesity (a BMI of 30 or above), or who are overweight (a BMI of 27 to 30) with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity

[15] In both trials, after 72 weeks of treatment, participants who received tirzepatide at all three dose levels experienced a statistically significant reduction in body weight compared to those who received placebo, and greater proportions of participants who received tirzepatide achieved at least 5% weight reduction compared to placebo

This digestive shift occurs because GLP-1 medications interact with receptors throughout the gut, changing how quickly food moves from your stomach into the intestines

Form: Injection